NuVasive, Inc.

476 articles about NuVasive, Inc.

• NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference

  12/28/2021

  NuVasive, Inc. announced today that Chief Executive Officer Chris Barry will virtually present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 12:00 p.m. PT/ 3:00 pm ET.

• NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference

  11/18/2021

  NuVasive, Inc. (NASDAQ: NUVA), announced today that NuVasive CEO J. Christopher Barry will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

• NuVasive Announces Third Quarter 2021 Financial Results

  11/9/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2021.

• NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference

  11/1/2021

  NuVasive, Inc. announced today that management will virtually present at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11, 2021 at 8:20 a.m. PT

• NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum '21

  10/28/2021

  NuVasive, Inc. today announced it will sponsor and participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '21 in Las Vegas from October 28 to 30, 2021.

• NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery

  10/27/2021

  NuVasive, Inc. (NASDAQ: NUVA), today announced the upcoming release of a cutting-edge virtual reality (VR) training module for the NuVasive X360® system to complement its market-leading Clinical Professional Development (CPD) program.

• NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results

  10/25/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter 2021 earnings results on Tuesday, November 9, 2021, after the close of the market.

• NuVasive Announces First Commercial Cases Utilizing the Pulse Platform

  9/30/2021

  Leading U.S. surgeons and hospitals complete first commercial cases with NuVasive's integrated enabling technology platform for spine surgery

• NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship

  9/22/2021

  NuVasive, Inc. announced it will continue its long-standing partnership with the Scoliosis Research Society with a double diamond sponsorship and will attend the society's 56th Annual Meeting from September 22 to 25, 2021 in St. Louis, Mo.

• NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery

  9/9/2021

  NuVasive, Inc. (NASDAQ: NUVA), today announced the NuVasive Simplify® Cervical Disc one-level U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study data was recently published in the International Journal of Spine Surgery.

• NuVasive to Present at Upcoming Investor Conference - Aug 30, 2021

  8/30/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that management will virtually present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 9:30 a.m. PT / 12:30 p.m. ET.

• NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch

  7/30/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that it received its latest U.S. Food and Drug Administration 510 clearance for the Pulse® platform, after receiving CE certification earlier this summer.

• NuVasive Announces Second Quarter 2021 Financial Results

  7/28/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2021.

• NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery

  7/22/2021

  NuVasive, Inc. announced today the commercial launch of Modulus ®  ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions.

• NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results

  7/14/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its second quarter 2021 earnings results on Wednesday, July 28, 2021, after the close of the market.

• NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations

  6/30/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that the Pulse® platform received CE Mark approval for its latest design update and clinical evaluations are underway in multiple countries throughout Europe.

• NuVasive Appoints Daniel J. Wolterman as Independent Board Chair

  5/19/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the appointment of Daniel J. Wolterman as independent chair of the NuVasive Board of Directors, effective immediately.

• NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations

  5/10/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Juliet C. Cunningham as the vice president of Investor Relations, effective immediately

• NuVasive Announces First Quarter 2021 Financial Results

  5/5/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2021.

• NuVasive to Present at Upcoming Investor Conferences

  5/3/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the following virtual investor conferences: